TSH Biopharm Corporation Limited (8432)
Market Closed
11 Aug, 05:30
TWSE 
HKEX Primary TWSE NT$
50. 40
-0.4
-0.7874%
NT$
- Market Cap
- P/E Ratio
0.02% Div Yield
22,160 Volume
- Eps
NT$ 50.8
Previous Close Want to track 8432 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TSH Biopharm Corporation Limited (8432) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.42B
Trailing P/E (ttm) 13.23
Forward P/E -
PEG ratio 0.3
Price/Sales (ttm) 1.46
Price/Book (mrq) 1.32
Enterprise Value/Revenue 1.06
Enterprise Value/EBITDA 5.47
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 41.01K
Average volume (90 days) 48.63K
Price summary
52-Week low 45.9
52-Week high 59.3
Beta -
50-Day moving average 50.5
200-Day moving average 51.78
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.61
Trailing annual dividend yield 0.0514%
5-Year annual dividend yield -
Payout ratio 0.5
Dividend Date 10 Jul 2026
Ex-Dividend Date 12 Jun 2026
Last split factor 1:1
Last split Date 28 Aug 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 34.77
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 4.25
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 27.85
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 6.44%
Book value per share (mrq) 45.67
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
